Zobrazeno 1 - 10
of 1 197
pro vyhledávání: '"Panoskaltsis N"'
Autor:
Panoskaltsis N; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. nicki.panoskaltsis@emory.edu.; BioMedical Systems Engineering Laboratory, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, USA. nicki.panoskaltsis@emory.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Apr; Vol. 70 (4), pp. 887-892. Date of Electronic Publication: 2021 Jan 08.
Autor:
de Janon A; BioMedical Systems Engineering Laboratory, Wallace H. Coulter Department of Biomedical Engineering, The Georgia Institute of Technology, Atlanta, GA., Mantalaris A; BioMedical Systems Engineering Laboratory, Wallace H. Coulter Department of Biomedical Engineering, The Georgia Institute of Technology, Atlanta, GA.; School of Pharmacy and Pharmaceutical Sciences, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.; National Institute for Bioprocessing Research and Training, Dublin, Ireland., Panoskaltsis N; BioMedical Systems Engineering Laboratory, Wallace H. Coulter Department of Biomedical Engineering, The Georgia Institute of Technology, Atlanta, GA.; School of Pharmacy and Pharmaceutical Sciences, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA.; Department of Haematology, St. James's Hospital Dublin, Dublin, Ireland.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2023 Apr 01; Vol. 210 (7), pp. 895-904.
Publikováno v:
In Food and Bioproducts Processing 2008 86(3):211-219
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Panoskaltsis, N1 n.panoskaltsis@imperial.ac.uk
Publikováno v:
Leukemia (08876924). Mar2005, Vol. 19 Issue 3, p354-357. 4p.
Publikováno v:
Leukemia (08876924). Apr2003, Vol. 17 Issue 4, p716. 15p.
Autor:
Perl AE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. alexander.perl@pennmedicine.upenn.edu., Hosono N; University of Fukui, Fukui, Japan., Montesinos P; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Podoltsev N; Yale School of Medicine, New Haven, CT, USA., Martinelli G; Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' IRST S. r. l, Meldola, Italy., Panoskaltsis N; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., Recher C; Cancer Research Center of Toulouse, Toulouse, France., Smith CC; University of California-San Francisco, San Francisco, CA, USA., Levis MJ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Strickland S; Vanderbilt Ingram Cancer Center, Nashville, TN, USA., Röllig C; Universitätsklinikum Carl Gustav Carus, Dresden, Germany., Groß-Langenhoff M; Astellas Pharma GmbH, Munich, Germany., Chou WC; National Taiwan University Hospital, Taipei, Taiwan., Lee JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Yokoyama H; Sendai Medical Center, National Hospital Organization, Sendai, Japan.; Tohoku University, National Hospital Organization, Sendai, Japan., Hasabou N; Astellas Pharma US, Northbrook, IL, USA., Lu Q; Astellas Pharma US, Northbrook, IL, USA., Tiu RV; Astellas Pharma US, Northbrook, IL, USA., Altman JK; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 May 30; Vol. 12 (5), pp. 84. Date of Electronic Publication: 2022 May 30.
Autor:
Harrison, CN, Mead, AJ, Panchal, A, Fox, S, Yap, C, Gbandi, E, Houlton, A, Alimam, S, Ewing, J, Wood, M, Chen, F, Coppell, J, Panoskaltsis, N, Knapper, S, Ali, S, Hamblin, A, Scherber, R, Dueck, AC, Cross, NCP, Mesa, R, McMullin, MF
Publikováno v:
Harrison, C N, Mead, A J, Panchal, A, McMullin, M, Fox, S, Yap, C, Gbandi, E, Houlton, A, Alimam, S, Ewing, J, Wood, M, Chen, F, Coppell, J, Panoskaltsis, N, knapper, S, Ali, S, Hmblin, A, Scherber, R, Dueck, A C, Cross, N & Rubin, M 2017, ' Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomised trial ', Blood, vol. 130, no. 17, pp. 1889 . https://doi.org/10.1182/blood-2017-05-785790
Treatments for high-risk essential thrombocythemia (ET) address thrombocytosis, disease-related symptoms, as well as risks of thrombosis, hemorrhage, transformation to myelofibrosis and leukemia. Patients resistant/intolerant to hydroxycarbamide (HC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::059a31dddd17c1bb8d460c966c1be861
https://doi.org/10.1182/blood-2017-05-785790
https://doi.org/10.1182/blood-2017-05-785790
Autor:
Allenby MC; Biological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, London, United Kingdom.; Faculty of Engineering, Centre for Biomedical Technologies, Queensland University of Technology (QUT), Brisbane, Australia., Okutsu N; Biological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, London, United Kingdom., Brailey K; Biological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, London, United Kingdom., Guasch J; Biological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, London, United Kingdom., Zhang Q; Biological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, London, United Kingdom., Panoskaltsis N; Biological Systems Engineering Laboratory, Department of Haematology, Imperial College London, London, United Kingdom.; Biomedical Systems Engineering Laboratory, Department of Hematology & Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Mantalaris A; Biological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, London, United Kingdom.; Biomedical Systems Engineering Laboratory, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
Publikováno v:
Tissue engineering. Part A [Tissue Eng Part A] 2022 Jan; Vol. 28 (1-2), pp. 38-53. Date of Electronic Publication: 2021 Sep 29.
Autor:
McCarthy NE; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK. n.e.mccarthy@qmul.ac.uk.; Centre for Immunobiology, The Blizard Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. n.e.mccarthy@qmul.ac.uk., Stagg AJ; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK.; Centre for Immunobiology, The Blizard Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Price CL; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK.; Lucid Group Communications, Buckinghamshire, UK., Mann ER; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Gellatly NL; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK., Al-Hassi HO; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK.; Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK., Knight SC; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK., Panoskaltsis N; Antigen Presentation Research Group, Imperial College London, Northwick Park and St. Mark's Campus, London, UK. nicki.panoskaltsis@emory.edu.; Department of Haematology, Imperial College London, Northwick Park and St. Mark's Campus, London, UK. nicki.panoskaltsis@emory.edu.; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA. nicki.panoskaltsis@emory.edu.; BioMedical Systems Engineering Laboratory, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA. nicki.panoskaltsis@emory.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Apr; Vol. 70 (4), pp. 1143-1153. Date of Electronic Publication: 2020 Oct 13.